Safety analysis of omitting axillary lymph node dissection in early-stage breast cancer with 1–2 sentinel lymph nodes macro-metastases: a meta-analysis

BackgroundCurrently, the axillary management strategy of omitting axillary lymph node dissection (ALND) in early-stage breast cancer (BC) patients with cT1-2, clinically node-negative (cN0), and sentinel lymph node biopsy (SLNB) revealing 1–2 sentinel lymph nodes (SLNs) macro-metastases remains cont...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yu Chen, Xiaoming Zhang, Qingping Wu, Shanshan Gao, Lu Wang, Minxia Zeng, Lihu Gu, Changrui Sheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2025-09-01
Edice:Frontiers in Oncology
Témata:
omitting
early-stage breast cancer
sentinel lymph node biopsy
axillary lymph node dissection
macro-metastases
meta-analysis
On-line přístup:https://www.frontiersin.org/articles/10.3389/fonc.2025.1620034/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky